(CLH) Clean Harbors - Ratings and Ratios
Waste Management, Industrial Services, Environmental Cleanup, Recycling
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 26.4% |
| Value at Risk 5%th | 40.8% |
| Relative Tail Risk | -6.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.28 |
| Alpha | -19.54 |
| CAGR/Max DD | 0.88 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.614 |
| Beta | 0.744 |
| Beta Downside | 0.561 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.86% |
| Mean DD | 6.81% |
| Median DD | 4.74% |
Description: CLH Clean Harbors October 31, 2025
Clean Harbors, Inc. (NYSE: CLH) operates two core segments in North America: Environmental Services, which handles the collection, treatment, and disposal of hazardous and non-hazardous waste-including incineration, landfill, wastewater treatment, and specialized laboratory chemical services-and Safety-Kleen Sustainability Solutions, which supplies containerized waste management, parts-washing, vacuum extraction, and lubricant manufacturing to automotive, industrial, and retail customers.
Key metrics and drivers: • FY 2023 revenue reached ≈ $5.7 billion, with an adjusted operating margin of ~13%, reflecting the high-margin nature of regulated waste-disposal contracts. • Hazardous-waste volume processed grew ~5% YoY, outpacing the broader industrial waste market, driven by tightening EPA hazardous-waste regulations and expanding chemical-manufacturing output. • The segment’s cash-flow conversion consistently exceeds 80%, giving the firm flexibility to invest in new treatment technologies and acquire regional competitors-a common growth path in the fragmented environmental-services sector.
If you’re looking to deepen the quantitative analysis of CLH’s valuation and risk profile, a quick look at ValueRay’s detailed financial models and scenario dashboards can provide the next layer of insight.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (388.4m TTM) > 0 and > 6% of Revenue (6% = 357.7m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 2.20pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 25.84% (prev 21.26%; Δ 4.58pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 815.6m > Net Income 388.4m (YES >=105%, WARN >=100%) |
| Net Debt (-498.7m) to EBITDA (1.12b) ratio: -0.45 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (53.7m) change vs 12m ago -0.95% (target <= -2.0% for YES) |
| Gross Margin 31.11% (prev 31.25%; Δ -0.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 80.32% (prev 79.35%; Δ 0.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.11 (EBITDA TTM 1.12b / Interest Expense TTM 163.5m) >= 6 (WARN >= 3) |
Altman Z'' 3.64
| (A) 0.20 = (Total Current Assets 2.61b - Total Current Liabilities 1.07b) / Total Assets 7.54b |
| (B) 0.35 = Retained Earnings (Balance) 2.67b / Total Assets 7.54b |
| (C) 0.09 = EBIT TTM 671.4m / Avg Total Assets 7.42b |
| (D) 0.52 = Book Value of Equity 2.46b / Total Liabilities 4.76b |
| Total Rating: 3.64 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 70.24
| 1. Piotroski 6.50pt |
| 2. FCF Yield 4.05% |
| 3. FCF Margin 7.43% |
| 4. Debt/Equity 0.09 |
| 5. Debt/Ebitda -0.45 |
| 6. ROIC - WACC (= 0.31)% |
| 7. RoE 14.61% |
| 8. Rev. Trend 85.49% |
| 9. EPS Trend 36.79% |
What is the price of CLH shares?
Over the past week, the price has changed by +4.31%, over one month by +14.71%, over three months by +0.47% and over the past year by -3.78%.
Is CLH a buy, sell or hold?
- Strong Buy: 7
- Buy: 3
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CLH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 250.3 | 5.5% |
| Analysts Target Price | 250.3 | 5.5% |
| ValueRay Target Price | 285.7 | 20.4% |
CLH Fundamental Data Overview November 26, 2025
P/E Trailing = 29.828
P/E Forward = 27.5482
P/S = 1.9345
P/B = 4.1778
P/EG = 188.43
Beta = 0.962
Revenue TTM = 5.96b USD
EBIT TTM = 671.4m USD
EBITDA TTM = 1.12b USD
Long Term Debt = 2.76b USD (from longTermDebt, last quarter)
Short Term Debt = 15.1m USD (from shortLongTermDebt, last quarter)
Debt = 260.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -498.7m USD (from netDebt column, last quarter)
Enterprise Value = 10.94b USD (11.53b + Debt 260.5m - CCE 850.4m)
Interest Coverage Ratio = 4.11 (Ebit TTM 671.4m / Interest Expense TTM 163.5m)
FCF Yield = 4.05% (FCF TTM 442.9m / Enterprise Value 10.94b)
FCF Margin = 7.43% (FCF TTM 442.9m / Revenue TTM 5.96b)
Net Margin = 6.51% (Net Income TTM 388.4m / Revenue TTM 5.96b)
Gross Margin = 31.11% ((Revenue TTM 5.96b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 32.33% (prev 33.32%)
Tobins Q-Ratio = 1.45 (Enterprise Value 10.94b / Total Assets 7.54b)
Interest Expense / Debt = 13.71% (Interest Expense 35.7m / Debt 260.5m)
Taxrate = 26.13% (42.0m / 160.8m)
NOPAT = 495.9m (EBIT 671.4m * (1 - 26.13%))
Current Ratio = 2.44 (Total Current Assets 2.61b / Total Current Liabilities 1.07b)
Debt / Equity = 0.09 (Debt 260.5m / totalStockholderEquity, last quarter 2.78b)
Debt / EBITDA = -0.45 (Net Debt -498.7m / EBITDA 1.12b)
Debt / FCF = -1.13 (Net Debt -498.7m / FCF TTM 442.9m)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.15% (Net Income 388.4m / Total Assets 7.54b)
RoE = 14.61% (Net Income TTM 388.4m / Total Stockholder Equity 2.66b)
RoCE = 12.38% (EBIT 671.4m / Capital Employed (Equity 2.66b + L.T.Debt 2.76b))
RoIC = 9.11% (NOPAT 495.9m / Invested Capital 5.44b)
WACC = 8.80% (E(11.53b)/V(11.79b) * Re(8.77%) + D(260.5m)/V(11.79b) * Rd(13.71%) * (1-Tc(0.26)))
Discount Rate = 8.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.50%
[DCF Debug] Terminal Value 79.11% ; FCFE base≈373.3m ; Y1≈460.3m ; Y5≈784.5m
Fair Price DCF = 217.6 (DCF Value 11.63b / Shares Outstanding 53.4m; 5y FCF grow 24.94% → 3.0% )
EPS Correlation: 36.79 | EPS CAGR: 27.45% | SUE: -0.88 | # QB: 0
Revenue Correlation: 85.49 | Revenue CAGR: 9.05% | SUE: -0.75 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.20 | Chg30d=-0.172 | Revisions Net=-5 | Analysts=8
EPS next Year (2026-12-31): EPS=7.99 | Chg30d=-0.765 | Revisions Net=-8 | Growth EPS=+10.2% | Growth Revenue=+3.9%
Additional Sources for CLH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle